Global Hepatitis E Diagnostic Tests Market (By Test Type (ELISA HEV IgM Test kits, ELISA HEV IgG test kits, RT-PCR Test kits, Others); By End-Users (Hospitals, Diagnostic, Laboratories, Point of Care, Research Centers)) – Prospective Landscape, Size, Share, Growth, Opportunities and Industry Forecast 2019-2028

Published DateReport CodeNo. of PagesReport Format
October – 2020AMR-9066110PDF / Excel
  • Global Hepatitis e diagnosis test market size was valued at US$ 48 million in 2019 and projected to reach US$ 71.33 million at a CAGR of 4.5 % over the forecast period between 2020 to 2028.

SelectLicense Type

Market Insights

Some significant factors such as growing awareness among people related to the early diagnosis of hepatitis E and hyper-endemicity of the disease in different global regions are boosting the market growth. Also, the higher growth rate of death among pregnant women has contributed to the rising screening for hepatitis E among pregnant women, which is increasing the global market revenue share of diagnostic laboratories. The modest growth in the hospital segment is increasing focus on screening for hepatitis E among the blood donors which is also propelling the global market growth.

Latest Trends

The following are the trending factors encouraging the global hepatitis e diagnostic tests  market over the forecast period:

  • The hyper-endemicity of hepatitis E in different emerging geographies across the Asia-Pacific
  • High prevalence of hepatitis E and the lack of proper sanitation and access to safe drinking water
  • The presence of leading key players in the global market
  • Increasing initiatives by government or non-government organizations.

Driving Factors

  • The global Hepatitis E Diagnostic Tests market is driven by various factors such as growing awareness among people related to the early diagnosis of HEV and increasing the presence of IgG titers in the test sample.
  • ELISA HEV IgM test kits are projected to be the remarkable test type segment over the forecast period owing to its rising applications in the diagnosis of hepatitis E infections and the growing seroprevalence of hepatitis E.
  • Also, increasing acute cases of infection contributing to the growth of ELISA HEV IgM test kits in the global market regions. Furthermore, the hyper-endemic prevalence of hepatitis E in different countries of the Asia Pacific and Africa is boosting the growth of diagnostic kits in the forecast period.
  • Furthermore, the global hepatitis e diagnosis tests market is growing day by day owing to per capita consumption in emerging economies and the largest consumption of the diagnostic tests in Asian economies such as Japan, India, and others.
  • Moreover, leading research centers and diagnostic laboratories are expected to mark notable footprints in the growth in the hepatitis E diagnostic tests market.

Restraining Factors

  • Rising costing structure may hamper the global market growth.

Segmentations

The global hepatitis e diagnostic tests market has been examined into different global market segments by analyzing numerous perspectives such as test type, end-users, and global geographies. Based on test type, it can be divided into ELISA HEV IgM Test kits, ELISA HEV IgG test kits, RT-PCR Test kits, and Others. Based on end-users, it can be divided into Hospitals, Point of Care, Research Centers, and Diagnostic Laboratories.

Test Type Perspective (Revenue in US$ Million):

  • ELISA HEV IgM Test kits
  • ELISA HEV IgG test kits
  • RT-PCR Test kits
  • Others

End-Users Perspective (Revenue in US$ Million):

  • Hospitals
  • Point of Care
  • Research Centers
  • Diagnostic Laboratories

Regional Perspective (Revenue in USD Billion):

  • North America
    • U.S.A
    • Canada
  • Europe
    • Italy
    • Germany
    • France
    • UK
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

Regional Insights

  • The global hepatitis e diagnostic tests market has been scrutinized into various global market regions including North America, Asia-Pacific, Africa, and Europe, Latin America, and the Middle East based on various global market segments and sub-segments.
  • Asia Pacific was marking the notable growth for the hepatitis E diagnostic tests market and is projected to remain dominant over the forecast period. The Asia Pacific and the Middle East and Africa projected for the largest market share in 2018. The hyper-endemicity of hepatitis E in different emerging geographies such as India, Pakistan, Vietnam, Thailand, Kazakhstan, Nepal, Bhutan, Bangladesh, and Burma, among others is registering impressive growth in the global market.
  • Furthermore, various developed countries in Africa such as Uganda, Kenya, Morocco, and Nigeria are contributing to the high revenue share for the hepatitis E diagnostic tests market.
  • Asia Pacific region is marking the notable growth for the global Hepatitis E Diagnostic Tests market in 2018 due to the high prevalence of hepatitis E and the lack of proper sanitation and access to safe drinking water are major factors driving the growth of the global market.
  • Additionally, hepatitis E is hyper-endemic in different countries of Asia Pacific countries such as India, Pakistan, Nepal, Vietnam, Thailand, and Burma, Bangladesh, Kazakhstan, and others are contributing to the growth of the global market. Furthermore, the presence of leading key players in the global region contributes to the increasing market growth.
  • North America dominated the largest market share in 2016 owing to the increasing availability of advanced diagnostic tools and growing awareness about these products. The accelerated growth in the Canadian market is contributed due to various factors such as increasing initiatives by government or non-government organizations.

Key Industry Players

Leading global companies in the global hepatitis e diagnostic tests market have been analyzed and listed to obtain informative data on different perspectives for understanding the competitive landscape of the global market. Furthermore, it sheds light on various attributes such as company overview, effective business strategies, financial overview, product benchmarking, demand-supply chaining, and a holistic snapshot of global competition among leading companies.

The following global key players have been profiled to get better insights about business strategies carried out by global companies:

  • Altona Diagnostics GmbH
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
  • Biokit S.A
  • Primerdesign Ltd
  • Mikrogen GmBH
  • MP Biomedicals, LLC
  • Pro – Diagnostic Bioprobes s.r.l
  • Hoffmann-La Roche Ltd
  • Fast-track diagnostics Ltd
  • Fortress Diagnostics Limited

Key Industry Developments

Leading companies in the global market such as Mikrogen GmBH, MP Biomedicals, LLC, Dia Pro – Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd, and Fast-track diagnostics Ltd are focusing on R & D for introducing innovations in tests.

This report answers the following key questions:

  • What is the global hepatitis e diagnostic tests market?
  • What is the impact of Covid-19 on the global hepatitis e diagnostic tests market?
  • What is the contribution of the government sector for boosting the hepatitis e diagnostic tests market?
  • What are the technological advancements and latest trends in the hepatitis e diagnostic tests market?
  • Which are the major segments accounted for holding the largest share in the hepatitis e diagnostic tests market?
  • What was the global market size and market share in historical years?
  • What are the major challenges faced by global key players in the hepatitis e diagnostic tests market?
  • What are the global companies functioning in the hepatitis e diagnostic tests market?
  • Which factors are encouraging and supporting the hepatitis e diagnosis tests market?
  • What will be the global market growth opportunities in the hepatitis e diagnosis tests market?

Report Synopsis

Alchemy Market Research has recently added an informative analysis of the global hepatitis e diagnosis tests market to its large volume of database. The global hepatitis e diagnosis test market size was valued of USD 48 million in 2019 and is expected to register a CAGR of 4.5 % over the forecast period. The global market research report provides an outlook of the global hepatitis e diagnosis tests market based on various prospects for the market. Also, it offers qualitative insights, historical data, and verifiable projections about the global market size over the forecast period. This research report presented as a database for analysis and information for different facets such as regional markets, technology, types, end-users, applications in the global market. Additionally, this informative report presents an understanding of the target market and has been accumulated with the help of primary and secondary research techniques. These two methods are used for collaborating precise data regarding the global market dynamics, historical events, market sizing, and present scenario of the market.

Chapter 1. Executive Summary

Chapter 2. Market Introduction

Chapter 3. Global Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028 – Key Industry Dynamics

3.1. Key Market Drivers
3.2. Key Market Restraints
3.3. Market Opportunities
3.4. Future Trends
3.5. Impact Analysis of Drivers and Restraints

Chapter 4. Global Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

Chapter 5. Global Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028 – By Test Type

5.1. ELISA HEV IgM Test kits
5.2. ELISA HEV IgG test kits
5.3. RT-PCR Test kits
5.4. Others

Chapter 6. Global Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028 – By End-Users

6.1. Hospitals
6.2. Point of Care
6.3. Research Centers
6.4. Diagnostic Laboratories

Chapter 7. Global Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028 – By Region

7.1. North America
7.2. Europe
7.3. Asia-Pacific
7.4. Latin America
7.5. Middle East & Africa

Chapter 8. North America Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

8.1. North America Hepatitis E Diagnosis Tests Market– By Test Type

8.1.1. Outsourcing
8.1.2. Offshoring

8.2. North America Hepatitis E Diagnosis Tests Market– By End-Users

8.2.1. Hospitals
8.2.2. Point of Care
8.2.3. Research Centers
8.2.4. Diagnostic Laboratories

8.3. North America Hepatitis E Diagnosis Tests Market– By Country

8.3.1. U.S.
8.3.2. Canada

Chapter 9. Europe Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

9.1. Europe Hepatitis E Diagnosis Tests Market– By Test Type

9.1.1. Outsourcing
9.1.2. Offshoring

9.2. Europe Hepatitis E Diagnosis Tests Market– By End-Users

9.2.1. Hospitals
9.2.2. Point of Care
9.2.3. Research Centers
9.2.4. Diagnostic Laboratories

9.3. Europe Hepatitis E Diagnosis Tests Market– By Country

9.3.1. Germany
9.3.2. France
9.3.3. UK
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe

Chapter 10. Asia Pacific Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

10.1. Asia Pacific Hepatitis E Diagnosis Tests Market– By Test Type

10.1.1. Outsourcing
10.1.2. Offshoring

10.2. Asia Pacific Hepatitis E Diagnosis Tests Market– By End-Users

10.2.1. Hospitals
10.2.2. Point of Care
10.2.3. Research Centers
10.2.4. Diagnostic Laboratories

10.3. Asia-Pacific Hepatitis E Diagnosis Tests Market– By Country

10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Rest of Asia-Pacific

Chapter 11. Latin America Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

11.1. Latin America Hepatitis E Diagnosis Tests Market– By Test Type

11.1.1. Outsourcing
11.1.2. Offshoring

11.2. Latin America Hepatitis E Diagnosis Tests Market– By End-Users

11.2.1. Hospitals
11.2.2. Point of Care
11.2.3. Research Centers
11.2.4. Diagnostic Laboratories

11.3. Latin America Hepatitis E Diagnosis Tests Market– By Country

11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America

Chapter 12. Middle East & Africa Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

12.1. Middle East & Africa Hepatitis E Diagnosis Tests Market– By Test Type

12.1.1. Outsourcing
12.1.2. Offshoring

12.2. Middle East & Africa Hepatitis E Diagnosis Tests Market– By End-Users

12.2.1. Hospitals
12.2.2. Point of Care
12.2.3. Research Centers
12.2.4. Diagnostic Laboratories

12.3. Middle East & Africa Hepatitis E Diagnosis Tests Market– By Country

12.3.1. UAE
12.3.2. Saudi Arabia
12.3.3. Turkey
12.3.4. Rest of Middle East & Africa

Chapter 13. Competitive Analysis

13.1.1. Competition Dashboard
13.1.2. Company Profiles

13.1.2.1. Altona Diagnostics GmbH
13.1.2.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
13.1.2.3. Biokit S.A
13.1.2.4. Primerdesign Ltd
13.1.2.5. Mikrogen GmBH
13.1.2.6. MP Biomedicals, LLC
13.1.2.7. Dia.Pro – Diagnostic Bioprobes s.r.l
13.1.2.8. F. Hoffmann-La Roche Ltd
13.1.2.9. Fast-track diagnostics Ltd
13.1.2.10. Fortress Diagnostics Limited

Report Description

Market Insights

Some significant factors such as growing awareness among people related to the early diagnosis of hepatitis E and hyper-endemicity of the disease in different global regions are boosting the market growth. Also, the higher growth rate of death among pregnant women has contributed to the rising screening for hepatitis E among pregnant women, which is increasing the global market revenue share of diagnostic laboratories. The modest growth in the hospital segment is increasing focus on screening for hepatitis E among the blood donors which is also propelling the global market growth.

Latest Trends

The following are the trending factors encouraging the global hepatitis e diagnostic tests  market over the forecast period:

  • The hyper-endemicity of hepatitis E in different emerging geographies across the Asia-Pacific
  • High prevalence of hepatitis E and the lack of proper sanitation and access to safe drinking water
  • The presence of leading key players in the global market
  • Increasing initiatives by government or non-government organizations.

Driving Factors

  • The global Hepatitis E Diagnostic Tests market is driven by various factors such as growing awareness among people related to the early diagnosis of HEV and increasing the presence of IgG titers in the test sample.
  • ELISA HEV IgM test kits are projected to be the remarkable test type segment over the forecast period owing to its rising applications in the diagnosis of hepatitis E infections and the growing seroprevalence of hepatitis E.
  • Also, increasing acute cases of infection contributing to the growth of ELISA HEV IgM test kits in the global market regions. Furthermore, the hyper-endemic prevalence of hepatitis E in different countries of the Asia Pacific and Africa is boosting the growth of diagnostic kits in the forecast period.
  • Furthermore, the global hepatitis e diagnosis tests market is growing day by day owing to per capita consumption in emerging economies and the largest consumption of the diagnostic tests in Asian economies such as Japan, India, and others.
  • Moreover, leading research centers and diagnostic laboratories are expected to mark notable footprints in the growth in the hepatitis E diagnostic tests market.

Restraining Factors

  • Rising costing structure may hamper the global market growth.

Segmentations

The global hepatitis e diagnostic tests market has been examined into different global market segments by analyzing numerous perspectives such as test type, end-users, and global geographies. Based on test type, it can be divided into ELISA HEV IgM Test kits, ELISA HEV IgG test kits, RT-PCR Test kits, and Others. Based on end-users, it can be divided into Hospitals, Point of Care, Research Centers, and Diagnostic Laboratories.

Test Type Perspective (Revenue in US$ Million):

  • ELISA HEV IgM Test kits
  • ELISA HEV IgG test kits
  • RT-PCR Test kits
  • Others

End-Users Perspective (Revenue in US$ Million):

  • Hospitals
  • Point of Care
  • Research Centers
  • Diagnostic Laboratories

Regional Perspective (Revenue in USD Billion):

  • North America
    • U.S.A
    • Canada
  • Europe
    • Italy
    • Germany
    • France
    • UK
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

Regional Insights

  • The global hepatitis e diagnostic tests market has been scrutinized into various global market regions including North America, Asia-Pacific, Africa, and Europe, Latin America, and the Middle East based on various global market segments and sub-segments.
  • Asia Pacific was marking the notable growth for the hepatitis E diagnostic tests market and is projected to remain dominant over the forecast period. The Asia Pacific and the Middle East and Africa projected for the largest market share in 2018. The hyper-endemicity of hepatitis E in different emerging geographies such as India, Pakistan, Vietnam, Thailand, Kazakhstan, Nepal, Bhutan, Bangladesh, and Burma, among others is registering impressive growth in the global market.
  • Furthermore, various developed countries in Africa such as Uganda, Kenya, Morocco, and Nigeria are contributing to the high revenue share for the hepatitis E diagnostic tests market.
  • Asia Pacific region is marking the notable growth for the global Hepatitis E Diagnostic Tests market in 2018 due to the high prevalence of hepatitis E and the lack of proper sanitation and access to safe drinking water are major factors driving the growth of the global market.
  • Additionally, hepatitis E is hyper-endemic in different countries of Asia Pacific countries such as India, Pakistan, Nepal, Vietnam, Thailand, and Burma, Bangladesh, Kazakhstan, and others are contributing to the growth of the global market. Furthermore, the presence of leading key players in the global region contributes to the increasing market growth.
  • North America dominated the largest market share in 2016 owing to the increasing availability of advanced diagnostic tools and growing awareness about these products. The accelerated growth in the Canadian market is contributed due to various factors such as increasing initiatives by government or non-government organizations.

Key Industry Players

Leading global companies in the global hepatitis e diagnostic tests market have been analyzed and listed to obtain informative data on different perspectives for understanding the competitive landscape of the global market. Furthermore, it sheds light on various attributes such as company overview, effective business strategies, financial overview, product benchmarking, demand-supply chaining, and a holistic snapshot of global competition among leading companies.

The following global key players have been profiled to get better insights about business strategies carried out by global companies:

  • Altona Diagnostics GmbH
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
  • Biokit S.A
  • Primerdesign Ltd
  • Mikrogen GmBH
  • MP Biomedicals, LLC
  • Pro – Diagnostic Bioprobes s.r.l
  • Hoffmann-La Roche Ltd
  • Fast-track diagnostics Ltd
  • Fortress Diagnostics Limited

Key Industry Developments

Leading companies in the global market such as Mikrogen GmBH, MP Biomedicals, LLC, Dia Pro – Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd, and Fast-track diagnostics Ltd are focusing on R & D for introducing innovations in tests.

This report answers the following key questions:

  • What is the global hepatitis e diagnostic tests market?
  • What is the impact of Covid-19 on the global hepatitis e diagnostic tests market?
  • What is the contribution of the government sector for boosting the hepatitis e diagnostic tests market?
  • What are the technological advancements and latest trends in the hepatitis e diagnostic tests market?
  • Which are the major segments accounted for holding the largest share in the hepatitis e diagnostic tests market?
  • What was the global market size and market share in historical years?
  • What are the major challenges faced by global key players in the hepatitis e diagnostic tests market?
  • What are the global companies functioning in the hepatitis e diagnostic tests market?
  • Which factors are encouraging and supporting the hepatitis e diagnosis tests market?
  • What will be the global market growth opportunities in the hepatitis e diagnosis tests market?
Report Synopsis

Report Synopsis

Alchemy Market Research has recently added an informative analysis of the global hepatitis e diagnosis tests market to its large volume of database. The global hepatitis e diagnosis test market size was valued of USD 48 million in 2019 and is expected to register a CAGR of 4.5 % over the forecast period. The global market research report provides an outlook of the global hepatitis e diagnosis tests market based on various prospects for the market. Also, it offers qualitative insights, historical data, and verifiable projections about the global market size over the forecast period. This research report presented as a database for analysis and information for different facets such as regional markets, technology, types, end-users, applications in the global market. Additionally, this informative report presents an understanding of the target market and has been accumulated with the help of primary and secondary research techniques. These two methods are used for collaborating precise data regarding the global market dynamics, historical events, market sizing, and present scenario of the market.

Table of Content

Chapter 1. Executive Summary

Chapter 2. Market Introduction

Chapter 3. Global Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028 – Key Industry Dynamics

3.1. Key Market Drivers
3.2. Key Market Restraints
3.3. Market Opportunities
3.4. Future Trends
3.5. Impact Analysis of Drivers and Restraints

Chapter 4. Global Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

Chapter 5. Global Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028 – By Test Type

5.1. ELISA HEV IgM Test kits
5.2. ELISA HEV IgG test kits
5.3. RT-PCR Test kits
5.4. Others

Chapter 6. Global Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028 – By End-Users

6.1. Hospitals
6.2. Point of Care
6.3. Research Centers
6.4. Diagnostic Laboratories

Chapter 7. Global Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028 – By Region

7.1. North America
7.2. Europe
7.3. Asia-Pacific
7.4. Latin America
7.5. Middle East & Africa

Chapter 8. North America Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

8.1. North America Hepatitis E Diagnosis Tests Market– By Test Type

8.1.1. Outsourcing
8.1.2. Offshoring

8.2. North America Hepatitis E Diagnosis Tests Market– By End-Users

8.2.1. Hospitals
8.2.2. Point of Care
8.2.3. Research Centers
8.2.4. Diagnostic Laboratories

8.3. North America Hepatitis E Diagnosis Tests Market– By Country

8.3.1. U.S.
8.3.2. Canada

Chapter 9. Europe Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

9.1. Europe Hepatitis E Diagnosis Tests Market– By Test Type

9.1.1. Outsourcing
9.1.2. Offshoring

9.2. Europe Hepatitis E Diagnosis Tests Market– By End-Users

9.2.1. Hospitals
9.2.2. Point of Care
9.2.3. Research Centers
9.2.4. Diagnostic Laboratories

9.3. Europe Hepatitis E Diagnosis Tests Market– By Country

9.3.1. Germany
9.3.2. France
9.3.3. UK
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe

Chapter 10. Asia Pacific Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

10.1. Asia Pacific Hepatitis E Diagnosis Tests Market– By Test Type

10.1.1. Outsourcing
10.1.2. Offshoring

10.2. Asia Pacific Hepatitis E Diagnosis Tests Market– By End-Users

10.2.1. Hospitals
10.2.2. Point of Care
10.2.3. Research Centers
10.2.4. Diagnostic Laboratories

10.3. Asia-Pacific Hepatitis E Diagnosis Tests Market– By Country

10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Rest of Asia-Pacific

Chapter 11. Latin America Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

11.1. Latin America Hepatitis E Diagnosis Tests Market– By Test Type

11.1.1. Outsourcing
11.1.2. Offshoring

11.2. Latin America Hepatitis E Diagnosis Tests Market– By End-Users

11.2.1. Hospitals
11.2.2. Point of Care
11.2.3. Research Centers
11.2.4. Diagnostic Laboratories

11.3. Latin America Hepatitis E Diagnosis Tests Market– By Country

11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America

Chapter 12. Middle East & Africa Hepatitis E Diagnosis Tests Market– Analysis and Revenue Forecast 2019-2028

12.1. Middle East & Africa Hepatitis E Diagnosis Tests Market– By Test Type

12.1.1. Outsourcing
12.1.2. Offshoring

12.2. Middle East & Africa Hepatitis E Diagnosis Tests Market– By End-Users

12.2.1. Hospitals
12.2.2. Point of Care
12.2.3. Research Centers
12.2.4. Diagnostic Laboratories

12.3. Middle East & Africa Hepatitis E Diagnosis Tests Market– By Country

12.3.1. UAE
12.3.2. Saudi Arabia
12.3.3. Turkey
12.3.4. Rest of Middle East & Africa

Chapter 13. Competitive Analysis

13.1.1. Competition Dashboard
13.1.2. Company Profiles

13.1.2.1. Altona Diagnostics GmbH
13.1.2.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
13.1.2.3. Biokit S.A
13.1.2.4. Primerdesign Ltd
13.1.2.5. Mikrogen GmBH
13.1.2.6. MP Biomedicals, LLC
13.1.2.7. Dia.Pro – Diagnostic Bioprobes s.r.l
13.1.2.8. F. Hoffmann-La Roche Ltd
13.1.2.9. Fast-track diagnostics Ltd
13.1.2.10. Fortress Diagnostics Limited

Report Sample
Report Methodology
Report Customization
Consult the Analyst